iTBS to Enhance Social Cognition in People With Psychosis
NCT: NCT06118268 · RECRUITING
Brief Summary
The goal of this clinical trial is to examine if iTBS applied to the DMPFC improves social cognitive performance compared to sham stimulation in people diagnosed with schizophrenia, schizoaffective disorder, schizophreniform disorder, or psychotic disorder not otherwise specified. The main objectives of this trial are: * Compare changes in social cognitive performance between the active vs. sham treatment groups * Compare changes in social cognitive network functional connectivity between the active vs. sham treatment groups Each participant will receive iTBS (active or sham) five days per week for four consecutive weeks. Functional magnetic resonance imaging (fMRI) scans, clinical assessments, and cognitive tests will be performed at pre-treatment, post-treatment, and 6 months after the completion of treatment.
Frequently Asked Questions
What is iTBS to Enhance Social Cognition in People With Psychosis?
iTBS to Enhance Social Cognition in People With Psychosis is a clinical trial registered under NCT06118268. Current status: RECRUITING.
What is the status of NCT06118268?
The current status of NCT06118268 (iTBS to Enhance Social Cognition in People With Psychosis) is: RECRUITING.
When did iTBS to Enhance Social Cognition in People With Psychosis start?
iTBS to Enhance Social Cognition in People With Psychosis started on 2023-04-18.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.